查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1247436

2023-2030 年全球视网膜植入物市场

Global Retinal Implants Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计2022年全球视网膜植入物市场规模将达到5978万美元，2030年将达到1.1817亿美元，预测期内（2023-2030年）复合年增长率为9.1%。据说

一种仿生眼，即视网膜假体或植入物，是一种可植入的电子设备，具有严重的视网膜疾病，例如年龄相关性黄斑变性和色素性视网膜炎，但视觉皮层和视神经不受影响。旨在刺激人们眼中的视觉感官。

市场动态

推动全球视网膜植入市场的主要因素是，由于需要适当治疗的眼部疾病数量不断增加，对先进设备的需求不断增长，意识提升活动激增，以及导致新产品发布的技术进步。

视网膜损伤的增加和老年人口的增加预计将推动市场的增长。

视网膜植入物市场随着植入物需求的增加、技术进步的加快、老年人口的增加、研发投资的激增、眼疾的增加以及最新技术的新增长以及新兴市场医疗基础设施的改善而不断增长。产品改进。

视网膜植入物被广泛用于刺激眼睛的视觉感官。 这些设备的日益普及导致政府加大了努力和资金投入。 这些资金将有助于生产更多用于治疗视网膜色素变性的产品，包括 PRIMA、IRIS V2 和 Argus II。 由于患有视网膜疾病的人数不断增加，视网膜植入物的市场正在全球范围内扩大。 此外，预计主要参与者提供的技术先进的产品也将在市场增长中发挥重要作用。

与这些视网膜植入物相关的各种新产品发布、研究和提高认识活动正在促进市场的增长。 例如，2022 年 1 月 31 日，Bionic Vision Technologies (BVT) 宣布世界上第一个澳大利亚仿生眼系统获得美国食品和药物管理局颁发的突破性设备称号。 这项突破性技术为因遗传性疾病视网膜色素变性 (RP) 而失明的人们提供了功能性视力。

与视网膜疾病相关的治疗费用飙升预计会阻碍市场增长。

然而，与视网膜植入物相关的报销政策的不确定性是製约市场增长的主要因素。 这种不确定性阻碍了临床医生和患者采用这些设备。

此外，与视网膜疾病相关的高昂治疗费用也是抑制视网膜植入市场增长的一个因素。 像 Argus II 这样的高级植入物的价格约为 115,000 美元至 150,000 美元。 生活在低收入和中等收入国家的人们买不起如此昂贵的产品。

COVID-19 影响分析

疫情对全球金融预期、业务运营和危机应对策略产生了负面影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于 COVID，视网膜植入物市场遭受了巨大损失。 主要製造商已经启动了各种研究和临床试验。

世界各地正在开展各种举措、产品发布、合作和合併，促进了市场的增长。 提高公众对视网膜相关眼病及其治疗的认识也将在未来推动市场。

内容

第 1 章研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 视网膜损伤增加
      • 人口老龄化将会增加
    • 约束因素
      • 飙升的治疗费用
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析

第 6 章 COVID-19 分析

  • 市场上 COVID-19 的分析
    • 在 COVID-19 市场情景之前
    • 当前的 COVID-19 市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第 7 章按产品类型

  • Argus II 视网膜假体系统
  • 视网膜植入物αIMS
  • 视网膜光植入物 (PRIMA)
  • EPI-RET3
  • 智能视网膜植入系统 (IRIS V2)
  • 脉络膜上膜视网膜假体
  • 视网膜下假体

第 8 章（按植入物类型）

  • 视网膜前
  • 视网膜下
  • 超脉线

第 9 章按应用

  • 视网膜色素变性
  • 年龄相关性黄斑变性
  • 糖尿病眼病
  • 视网膜脱离

第 10 章最终用户

  • 医院
  • 门诊手术中心
  • 眼科中心

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 知名大公司名单

第13章公司简介

  • 仿生视觉技术
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Vivani Medical, Inc.
  • Samsara Vision Inc.
  • Visus Technology Inc.
  • Pixium Vision
  • Nano Retina
  • Labtician Ophthalmics, Inc.
  • VisionCare, Inc.
  • Cicor Management AG
  • Second Sight Medical Products Inc.

第14章 DataM

简介目录
Product Code: MD1303

Market Overview

The global retinal implants market size was valued at US$ 59.78 million in 2022 and is estimated to reach US$ 118.17 million by 2030, growing at a CAGR of 9.1% during the forecast period (2023-2030).

Retinal prostheses or implants, a kind of bionic eye, are electronic devices which are implantable and are designed to stimulate vision sensation in the eyes of people with significant retinal disorders such as age-related macular degeneration or retinitis pigmentosa, where the visual cortex or optic nerve are unaffected.

Market Dynamics

The major factors driving the global retinal implants market are the rising demand for advanced devices owing to increasing incidences of ocular disorders requiring proper treatment, surging awareness initiatives, advancements in technologies leading to novel product launches.

The increasing number of retinal damages and rising geriatric populations are expected to drive the market's growth.

The retinal implants market is driven by increasing demand of implants, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ocular diseases and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The retinal implants are used widely for stimulating the eye vision sensation. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce more developed products such as PRIMA, IRIS V2 and Argus II for treating retinal pigmentosa. The market for these retinal implants is increasing worldwide due to the enhanced number of people suffering from retinal disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these Retinal Implants contribute to the market's growth. For instance, in Jan 31, 2022, Bionic Vision Technologies (BVT) announced about world-first Bionic Eye System of Australia has received breakthrough device designation from the Food and Drug Administration in the United States. This ground-breaking technology provides functional vision to people who due to Retinitis Pigmentosa (RP), the genetic condition, lost their sight.

High cost of treatment associated with retinal disorders are expected to hamper the market's growth.

However, uncertain reimbursement policies associated with these retinal implants is the key factor which may hamper the market growth. Due to the uncertainty clinicians as well as patients hesitate in adopting these devices.

The high cost of treatments associated with these retinal disorders is also a factor hindering the growth of the retinal implants market. The highly advanced implants such as Argus II cost around $115,000 to $150,000. The people living in low or middle income countries can't afford such expensive products.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The retinal implants market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials.

Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. The increasing awareness among the population regarding the ocular disorders related to retina and their treatment will also drive the market in upcoming time.

Segment Analysis

The Argus II retinal prosthesis systems segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The Argus II Retinal Prosthesis System segment is the highest market holder in the global retinal implants market. The global retinal implants market is segmented based on product type as Argus II Retinal Prosthesis System, Retina Implant Alpha IMS, Photovoltaic Retinal Implant (PRIMA), EPI-RET3, Intelligent Retinal Implant System (IRIS V2), Suprachoroidal Retinal Prosthesis, Subretinal Retinal Prosthesis. The Argus II Retinal Prosthesis Systems segment is the largest market shareholder due to the increasing adoption of these devices globally as implants, increasing technological advancements and novel product launches.

The Argus II is an epiretinal, micro-electrode array retinal prosthesis of second-generation developed and marketed by Second Sight Medical Products. It was approved for commercialization in both the United States and Europe, became the first device to receive that distinction. The design of it differs from the Argus I, the first generation model, in the spacing and number of microelectrodes on the array, the internal processing components placement (instead of subcutaneous placement in the temporal recess it is sutured onto the sclera), and the external transmission coil placement (instead of held magnetically by the internal components across the temporal bone it is built into the sidearm of the glasses).

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market's growth. For instance, in March 5, 2021, Second Sight Medical Products, a developer and seller of implantable visual prosthetics intended to develop a useful vision's artificial form for blind individuals, announced about receiving approval for the Argus 2s Retinal Prosthesis System by the U.S. Food and Drug Administration (FDA). Argus II is a redesigned external hardware (video processing unit) set initially for utilization for the treatment of retinitis pigmentosa (RP) in combination with already implanted Argus II systems.

Geographical Analysis

North America holds the largest market share in the global retinal implants market.

North America dominates the global retinal implants market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of retinal implants such as Retina Implant Alpha IMS, Photovoltaic Retinal Implant (PRIMA) and EPI-RET3, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the retinal implants market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in September 6, 2021, Bionic Vision Technologies (BVT) announced its strategic partnership with Cirtec Medical, a US MedTech company. Under this partnership, Cirtec received a strategic stake in Bionic and will further assist them in developing and producing its next-generation bionic eye.

Competitive Landscape

The retinal implants market is moderately competitive with local and global companies' presence. Bionic Vision Technologies, Vivani Medical, Inc., Samsara Vision Inc., Visus Technology Inc., Pixium Vision, Nano Retina, Labtician Ophthalmics, Inc., VisionCare, Inc., Cicor Management AG, Second Sight Medical Products Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in February 24, 2021, Diagnos Inc., a FLAIRE platform based on Artificial Intelligence (AI) developer, announced its strategic agreement of partnership with Labtician Ophthalmics, a Toronto-based company introducing and marketing DIAGNOS AI platform for ocular health monitoring and improve patient care.

Bionic Vision Technologies

Overview: Bionic Vision Technologies Pty Ltd is a medical device company based in Australia that is focused in preserving and restoring a sense of vision by creating a range of best technologies for meeting the needs of people having degenerative retinal conditions. BVT is marketing the technologies developed by Bionic Vision Australia (BVA).

Product Portfolio:

Argus II Retinal Prosthesis: It is a redesigned external hardware (video processing unit) set initially for utilization for the treatment of retinitis pigmentosa (RP) in combination with already implanted Argus II systems

The global retinal implants market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Number Of Retinal Damages
      • 4.1.1.2. Rising Geriatric Population
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost Of Treatments
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Argus II Retinal Prosthesis System*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 7.3. Retina Implant Alpha IMS
  • 7.4. Photovoltaic Retinal Implant (PRIMA)
  • 7.5. EPI-RET3
  • 7.6. Intelligent Retinal Implant System (IRIS V2)
  • 7.7. Suprachoroidal Retinal Prosthesis
  • 7.8. Subretinal Retinal Prosthesis

8. By Implants Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 8.1.2. Market Attractiveness Index, By Implants Type
  • 8.2. Epiretinal *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Subretinal
  • 8.4. Suprachoroidal

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Retinitis Pigmentosa *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Age-Related Macular Degeneration
  • 9.4. Diabetic Eye Disease
  • 9.5. Retinal Detachment

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Eye-care Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Bionic Vision Technologies *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Vivani Medical, Inc.
  • 13.3. Samsara Vision Inc.
  • 13.4. Visus Technology Inc.
  • 13.5. Pixium Vision
  • 13.6. Nano Retina
  • 13.7. Labtician Ophthalmics, Inc.
  • 13.8. VisionCare, Inc.
  • 13.9. Cicor Management AG
  • 13.10. Second Sight Medical Products Inc.

LIST NOT EXHAUSTIVE

14. Global Retinal Implants Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Medications
  • 14.3. Contact Us